| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Halter | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $425.51M | Series E | 3/24/2026 | $220M | $2B | $40.14 | Founders Fund, Blackbird Ventures, DCVC, BOND, Bessemer Venture Partners, NewView Capital, Ubiquity Ventures, Promus Ventures, Icehouse Ventures | ||||
 | Notice | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Pex | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $14.79M | Series C-2 | 2/18/2026 | $5M | $98.91M | $4.78 | Undisclosed Investors | ||||
 | Ratio Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $151.27M | Series C | 7/31/2026 | $70M | $398.34M | $43.69 | Duquesne Family Office, Bristol Myers Squibb, Catalio Capital Management, Eli Lilly and Company, Wasatch Group | ||||
 | Redo Tech | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $114.25M | Series B-4 | 9/10/2026 | $7M | $1.52B | $38.03 | Undisclosed Investors | ||||
 | Vetcove | Consumer & Lifestyle Pets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | P-1 AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $72.5M | Series A-2 | 7/29/2026 | $21.25M | $349.18M | $13.23 | New Enterprise Associates, Cameron McCord, Nick Marwell, Jo Zhu Kennedy | ||||
 | Poetic | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $50M | Series A-1 | 6/10/2026 | $45.24M | $500M | $26.70 | Kleiner Perkins, OpenAI, Founders Fund, First Harmonic, Genius Ventures, 515 Ventures | ||||
 | Prime Intellect | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $1.1M | -- | 1 | -- | Not available | -- | -- | $149.58M | Series A-3 | 7/8/2026 | $85M | $1B | $52.65 | Radical Ventures, NVIDIA, Intel, Dell Technologies, John Schulman, Karim Atiyeh, Aaron Levie, Dwarkesh Patel, Milan Kovac, Winston Weinberg, Mike Knoop, Asher Spector, Jeff Wang, Rohan Anil, Matthew Prince, Brendan Foody, Devansh Pandey, Harrison Chase, Nic Ouporov | ||||
 | Reed Semiconductor | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $134.23M | Series D | 6/25/2026 | $94.88M | $672.39M | $9.00 | Undisclosed Investors | ||||
 | TeamHealth | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Vention | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $239.18M | Class D | 1/27/2026 | $85.69M | $1.01B | $231.03 | Investissement Quebec, Desjardins Capital, Fidelity, NVentures | ||||
 | Dream Labs | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $90.08M | Series Seed-1 | 6/30/2026 | $85.69M | $387.75M | $29.22 | 500 Global | ||||
 | Ent AI | Missing Missing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $100M | Series Seed-3 | 6/16/2026 | $78.35M | $518.19M | $3.54 | Decibel Venture Capital, Sequoia Capital, Crosspoint Capital Partners, Craft Ventures, Shield Capital, Felicis, In-Q-Tel, DEV Capital, Firestreak Ventures | ||||
 | Mariana Minerals | Industrial Other Industrial | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $386.53M | Series B-1 | 8/3/2026 | $286.17M | $1.5B | $53.80 | Khosla Ventures, Andreessen Horowitz, Breakthrough Energy Ventures, Greenoaks, Halo Fund, Pax VC, StepStone Group, BHP Ventures, Washington Harbour Partners, Greycroft, General Innovation Capital Partners, Mitsubishi Corporation, In-Q-Tel, Earthshot Ventures | ||||
 | PowerLight Technologies | Energy Energy Efficiency | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Principal Mineral | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $208.8M | Series A-1 | 6/16/2026 | $201.1M | $637.78M | $29.32 | Overmatch Ventures, The New Industrial Corporation, J2 Ventures, Ensemble VC | ||||
 | Rectify Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Singularity | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $110.59M | Series A-1 | 7/14/2026 | $74.72M | $400M | $11.53 | Khosla Ventures, Felicis, AE Ventures, NEA, Long Journey, Harpoon, Menlo Ventures, Y Combinator, Decisive Point, New Vista Capital, Sunflower Capital, Soma Capital | ||||
 | Vi Labs | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Astrobotic | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | CaaMTech | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | MultiLynq | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | -- | Not available | -- | -- | -- | -- | -- | ||||
 | Odyssey | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | $125.01K | -- | 1 | -- | Not available | -- | -- | $336.9M | Series B | 6/17/2026 | $241.35M | $1.45B | $46.35 | Natural Capital, Amazon, AMD Ventures, GV, EQT, In-Q-Tel, Jeff Dean, Elad Gil, Qasar Younis, Garry Tan, Guillermo Rauch, Kyle Vogt, Samsung NEXT Ventures, Wyld VC, Nvidia, Evolution VC Partners | ||||